Skip to main content
Erschienen in: Insights into Imaging 1/2017

Open Access 07.11.2016 | Review

ASL and susceptibility-weighted imaging contribution to the management of acute ischaemic stroke

verfasst von: Sébastien Verclytte, Olivier Fisch, Lucie Colas, Olivier Vanaerde, Manuel Toledano, Jean-François Budzik

Erschienen in: Insights into Imaging | Ausgabe 1/2017

Abstract

Magnetic resonance imaging (MRI) plays a central role in the early diagnosis of cerebral vascular events. Today, MRI is used not only for the detection of acute ischaemic lesions, but also to fine tune the diagnosis and improve patient selection for early therapeutic decision-making. In this perspective, new tools such as arterial spin labelling (ASL) and susceptibility-weighted imaging (SWI) sequences have been developed. These MRI sequences enable noninvasive assessment of brain damage, providing important diagnostic and prognostic information: evaluation of cerebral parenchymal perfusion; detection and aetiological assessment of thrombi; ruling out differential diagnoses. After a brief recall of the fundamental basis of these sequences, this article proposes an update on their current contribution to the early management of stroke victims.

Teaching Points

These noninvasive sequences provide essential information for early management of acute stroke.
They can detect zones of parenchymal hypoperfusion.
Susceptibility-weighted sequences provide information on thrombus localisation and composition.
ASL can identify certain aetiologies of stroke mimics.
Post-therapeutic ASL perfusion status predicts outcome.

Introduction

MRI is an advanced tool for pre-therapeutic management of acute stroke. MRI can be used to assess the extent of brain infarction, localise the site of arterial occlusion, and search for evidence ruling out potential contraindications for thrombolysis. In recent years, the advent of 3-T MRI scanners for routine clinical applications has incited interest in new sequences exploiting the higher field strength, e.g. arterial spin labelling (ASL) and susceptibility-weighted imaging (SWI) sequences. This opens the way for new perspectives such as noninvasive assessment of parenchymal hypoperfusion, precise localisation of the thrombus and its origin, or characterisation of nonvascular stroke mimics. Here we propose an update on the contribution of these new techniques for acute-phase management of stroke patients.

SWI sequences

Fundamentals

These gradient-echo sequences are acquired with a long echo time (TE) in order to take full advantage of the magnetic susceptibility phenomenon. Magnetic susceptibility corresponds to the variation in the local magnetic field of a material exposed to an external magnetic field. This occurs for instance in the venous compartment, which contains a large amount of deoxyhaemoglobin, a highly paramagnetic substance. Paramagnetic substances create a field oriented in the same direction as the higher intensity main field, leading to a lower local signal. When a long TE is used, the dephasing resulting from spin-spin interactions and field heterogeneity is increased. TE can thus be set to yield a phase opposition phenomenon between deoxyhaemoglobin and the adjacent parenchyma, further lowering the signal [1]. Moreover, magnetic susceptibility evolves proportionally with the B0 magnetic field so that the phenomenon is more marked with 3 T than 1.5 T.
There are several types of susceptibility-weighted sequences. Susceptibility-weighted imaging (Siemens Heathcare, Erlangen, Germany) and Venobold (Philips Healthcare, Best, The Netherlands) are based exclusively on reading a long TE. Other sequences, such as susceptibility-weighted angiography (SWAN) (General Electrics Healthcare, Milwaukee, WI, USA) and susceptibility-weighted imaging with phase enhancement (SWIp) (Philips Healthcare, Best, The Netherlands), are based on reading multiple TEs set at long and short values. This method takes advantage of the more marked time-of-flight (TOF) effect when reading shorter TEs, adding to the magnetic susceptibility effect observed on longer TE images.

Applications for pre-therapeutic management of acute ischaemic stroke

Haemorrhagic transformation

Susceptibility-weighted sequences are much more sensitive for the detection of haemorrhagic transformation than either non-contrast CT scan or T2 gradient echo sequences. This greater sensitivity is important not only in the acute phase of ischaemic stroke, but is also highly contributive to the diagnosis of all types of intracranial bleeding [25].

Arterial thrombus

One of the major challenges for MRI exploration of acute stroke is to search for aetiological elements and factors predictive of post-therapeutic outcome. SWI sequences provide information on thrombus localisation and composition.
Intra-arterial signal voids on T2 gradient echo images, termed susceptibility vessel sign, were initially described as suggestive of cardioembolic thrombi [6, 7]. Indeed, those thrombi are mainly composed of red cells and thus blood degradation products have a strong paramagnetic effect compared with fibrin-rich atheromatous thrombi [8].
It appears that a more recently described two-layered susceptibility sign would be more sensitive and much more specific for cardioembolic thrombi than the susceptibility vessel sign (Fig. 1), which can arise via many mechanisms [9].
Whatever the origin of the thrombus, in acute ischaemic stroke, the susceptibility vessel sign would be correlated with:
  • a lower rate of recanalisation after intravenous thrombolysis compared with arterial occlusion without the susceptibility vessel sign [10, 11], particularly for proximal localisations [12], for lengths greater than 20 mm, for thrombi with irregular contours [13], and for susceptibility artefacts extending beyond the arterial lumen [14];
  • a favourable 3-month functional outcome in patients who undergo mechanical thrombectomy for anterior circulation occlusion [15], but not with a higher rate of recanalisation [16].
Because of its greater sensitivity, and particularly so with a strong magnetic field, SWI offers a more precise assessment of thrombus morphology. For determining the site of occlusion, SWI exhibits better sensitivity and specificity than T2 gradient echo (Fig. 2) or 3D TOF imaging [1719]. It is also much more effective in identifying distal thrombi, for both anterior [17, 20, 21] and posterior [19] localisations (Fig. 3). Detection of multiple distal thrombi is of major importance, since in this situation the 3-month functional outcome is less favourable compared with a unique occlusion [22]. However, distal thrombi may be confused with hypointense venous structures or microbleeds on SWI. The sequences based on a multi-TE readout are more efficient in doubtful cases. Indeed, the TOF effect related to the shortest TE read allows confirming the intra-arterial origin of the signal void assigned to the thrombus thanks to the susceptibility effect.

Brush sign

Thanks to the BOLD effect, SWI sequences can also be used to indirectly assess deoxyhaemoglobin content in peri-encephalic veins. Indeed, when exposed to experimental hypoxia, the venous compartment gives a proportionally lower signal that can be detected visually [23]. During acute ischaemia, the local oxygen deprivation secondary to arterial occlusion is seen as a hypointense zone in the cortical and deep veins called the brush sign [24], as multiple hypointense vessels [25], or as prominent vessel [26]. The presence of these signs in the acute phase is associated with a less severe clinical presentation (lower initial NIHSS score), lower lesion diffusion-weighted imaging (DWI) volume, more extensive penumbra, and more pronounced collaterals [25]. Moreover, the brush sign, reflecting cerebral hypoperfusion, would be correlated with penumbra volume. Luo et al. [27] demonstrated the absence of significant mismatch between DWI-MTT (mean transit time) maps produced by the dynamic susceptibility contrast MRI (DSC-MRI) and DWI-SWI maps (Fig. 4). Susceptibility-weighted sequences would thus enable effective noninvasive measurement of the penumbra in acute ischaemic stroke.
In the absence of thrombolytic treatment, the initial extent of the brush sign would be correlated with the final infarct volume and the severity of the functional outcome [26]. In case of middle cerebral artery occlusion treated by intravenous thrombolysis, the presence of a brush sign would be associated with a higher risk of haemorrhagic transformation and a less favourable 3-month functional outcome [28].

Arterial spin labelling

Fundamentals

Arterial spin labelling (ASL) is a brain perfusion sequence that does not require contrast injection. A salve of radiofrequency waves is applied to a box positioned in the neck area, upstream from the brain region to be studied in order to locally saturate the proton spins of the water molecules in the arterial blood and thus play the role of an endogenous contrast agent. After a certain transit time, which depends upon the subject’s age and circulatory conditions, the saturated protons reach the brain parenchyma generating the labelled image. A second acquisition is made without prior saturation of the water molecule spins, generating a control image. Subtraction of the labelled and control images generates a perfusion-weighted image used to produce an absolute measurement of cerebral blood flow (CBF). There are several types of ASL sequences. Continuous ASL (CASL), pulsed ASL (PASL), and pseudo-continuous (pCASL) are based on different excitation methods and present specific advantages and disadvantages.
In general, the CASL method has a higher signal-to-noise (S/N) ratio but induces an excessive specific absorption rate, particularly at 3 T. With PASL, labelling is particularly effective, but with a low S/N ratio. The pCASL method has the advantages of both the preceding methods, with a satisfactory S/N ratio and a limited specific absorption rate. It is currently recommended for clinical applications, preferably with turbo spin-echo 3D acquisition [29].
Post-labelling delay (PLD) should to be optimal for pCASL. This parameter should be adjusted on a case-by-case basis and correspond as closely as possible to the time needed for labelled protons to reach the region of interest. If the PLD is too short, all of the labelled bolus may not have time to fully integrate the parenchyma to be explored, particularly junctional areas. This can lead to a significant local signal loss, which could be misdiagnosed as false hypoperfusion regions. Patient-related factors can also lead to systemised false hypoperfusion areas, resulting for example from stenosis of the supra-aortic trunks, which produces a longer transit time between the labelling zone and the region of interest. In this case, it may be difficult to differentiate between false and real hypoperfusion, and other sequences, such as DWI or MR angiography, may be helpful to confirm the diagnosis.
Other artefacts related to the arterial transit can also occur. Seen as linear or serpingious hypersignals within the arteries of the Willis polygon, they are related to the persistence of labelled protons in the vascular compartment because of an overly short PLD. PLD is thus an essential parameter that must be adjusted to the patient’s circulatory status.
Standardised PLD values have been validated for patient age and pathological condition: 1500 ms for children; 1800 ms for healthy adults aged <70 years, and 2000 ms for adults aged >70 years or for patients with a suspected neurological condition, irrespective of the origin [29].
It should be pointed out that ASL is sensitive to motion. It is recommended to use background suppression and prospective correction methods to reduce motion artefacts [29]. However, in cases of highly agitated or confused patients, good quality ASL maps remain difficult to obtain.

Applications for the exploration of acute ischaemic stroke

Evaluation of the penumbra zone and DWI/perfusion mismatch

Several 3-T MRI studies have provided objective evidence of the good correlation among computed tomography perfusion, DSC-MRI, and ASL for determining zones of parenchymal hypoperfusion in acute stroke (Fig. 4) [3033]. Thus ASL provides a reliable assessment of penumbra volume based on the following CBF values:
  • ASL-CBF <20 ml/100 g/min. This is correlated with MTT >10 s on DSC-MRI [34];
  • ASL-CBF 40 % lower than in healthy contralateral tissue. Lesion volumes thus determined are correlated with volumes measured on computed tomography perfusion maps (Tmax 5.5 s) and DSC-MRI (Tmax + 6 s) as well as with the 24-h DWI lesion in patients without reperfusion [30].
ASL reliability and reproducibility have been established for 3-T assessment of penumbra volume, while the lower S/N ratio hampers 1.5-T performance [35].

Localisation of the arterial thrombus

During the acute phase of ischaemic stroke, a bright vessel appearance on ASL sequences localises the thrombus (Fig. 5). This bright vessel sign corresponds to an accumulation of protons in labelled arterial blood immediately upstream from the arterial occlusion. The sensitivity of the bright vessel sign would be superior to that of the susceptibility vessel sign [3638]. The bright vessel sign can also reveal certain distal arterial occlusions not initially detected on the vascular sequences, e.g. 3D TOF sequences [38].

Post-therapeutic hyperperfusion

When early arterial recanalisation occurs after intravenous thrombolysis, focal zones of hyperperfusion, termed luxury perfusion, can appear within the initial hypoperfusion zone. These zones are sometimes visible only on the ASL sequences and not on DSC-MRI, further complicating their interpretation [3941].
Thus the presence of hyperperfusion zones on the ASL sequences of a control MRI early after thrombolysis is associated with improved functional outcome at 24 h and 3 months and with a smaller final infarct volume [39, 40]. These zones of hyperperfusion would correspond to preserved regions that achieve restitutio ad integrum after the acute episode [40] (Fig. 6).
In opposition, there is ongoing debate on how early hyperperfusion zones would be associated with haemorrhagic risk since the available evidence is contradictory [40, 41]. Nevertheless, outcome would be better in hyperperfusion patients independently of the presence or not of haemorrhagic transformation [40]. Post-therapeutic ASL perfusion status predicts outcome.

Diagnosis of stroke mimics

Stroke mimics are non-vascular neurological pathologies that reproduce the symptoms of stroke. According to the literature, they occur in 1 to 14.5 % [4248] of patients treated with intravenous thrombolysis for suspected acute stroke, with a mean of 4.38 % [46]. These different studies report that these patients have a low risk of haemorrhage, estimated at 0 to 1 %, and a better functional prognosis than patients who undergo thrombolysis for confirmed ischaemic stroke [49]. There is however a significant treatment-related cost increment, estimated at $5400 in one American study [49]. These elements should incite efforts to optimise candidate selection for thrombolysis.
In order of frequency, the causes of stroke mimics are: partial epilepsy and psychiatric disorders, and then at variable frequencies depending on the report, infectious diseases (meningitis and meningoencephalitis), migraine with aura, brain tumours, cortical vein thrombosis, demyelinating inflammatory diseases, and metabolic or toxic pathologies. ASL can identify certain aetiologies of stroke mimics.
When there is an epileptic origin, ASL imaging shows focal hyperperfusion during the ictal and early post-ictal phases with increased CBF in the epileptogenic grey matter [5052]. These zones of hyperperfusion are not limited to a single cerebral vessel territory and are frequently associated with suggestive morphological anomalies such as hypersignals from the pulvinars or the splenium of the corpus callosum on FLAIR and DWI sequences [53] (Fig. 7). ASL can also identify epileptogenic foci, which develop in ischaemic scar tissue in patients given emergency care for suspected recurrent stroke in a previous infarction zone, demonstrating high flow rate zones situated on the borders of parenchymatous sequelae (Fig. 8). In the inter-ictal phase, ASL can identify epileptogenic foci located in focal hypoperfusion zones [54].
In migraine aura, perfusion imaging can reveal anomalous focal brain perfusion with a long MTT and decreased CBF and cerebral blood volume [55, 56]. In this situation ASL can also identify areas of decreased CBF [53]. These perfusion anomalies can sometimes resemble those observed in ischaemic stroke and may be associated with a brush sign [57] (Fig. 9), but are frequently bilateral, involving more than a single vascular territory, and predominating in posterior regions [53].
If the imaging is obtained late, at the headache phase, ASL reveals hyperperfusion with increased CBF [53, 58] that can be difficult to distinguish from other stroke mimics such as potential luxury perfusion. Nevertheless, the clinical presentation is usually sufficient to successfully guide diagnosis [53].

Conclusion

SWI and ASL sequences take advantage of the stronger magnetic field and have demonstrated their contribution to 3-T MRI exploration of acute ischaemic stroke. SWI provides prognostic elements useful for identifying the localisation, morphology, and aetiology of the thrombus, as well as the extent of the parenchymal hypoperfusion, while improving the spatial resolution and sensitivity of T2 gradient-echo sequences for the detection of haemorrhagic transformation. ASL should not be used as a routine sequence because of the acquisition time, but provides precious information for the differential diagnosis in specific situations, giving insight into the early post-therapeutic outcome and a noninvasive assessment of the penumbra.

Compliance with ethical standards

Conflict of interest

None.

Funding

None
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Literatur
1.
Zurück zum Zitat Hodel J, Rodallec M, Gerber S, Blanc R, Maraval A, Caron S et al (2012) Susceptibility weighted magnetic resonance sequences “SWAN, SWI and VenoBOLD”: technical aspects and clinical applications. J Neuroradiol J Neuroradiol 39(2):71–86CrossRefPubMed Hodel J, Rodallec M, Gerber S, Blanc R, Maraval A, Caron S et al (2012) Susceptibility weighted magnetic resonance sequences “SWAN, SWI and VenoBOLD”: technical aspects and clinical applications. J Neuroradiol J Neuroradiol 39(2):71–86CrossRefPubMed
2.
Zurück zum Zitat Wycliffe ND, Choe J, Holshouser B, Oyoyo UE, Haacke EM, Kido DK (2004) Reliability in detection of hemorrhage in acute stroke by a new three-dimensional gradient recalled echo susceptibility-weighted imaging technique compared to computed tomography: a retrospective study. J Magn Reson Imaging JMRI 20(3):372–377CrossRefPubMed Wycliffe ND, Choe J, Holshouser B, Oyoyo UE, Haacke EM, Kido DK (2004) Reliability in detection of hemorrhage in acute stroke by a new three-dimensional gradient recalled echo susceptibility-weighted imaging technique compared to computed tomography: a retrospective study. J Magn Reson Imaging JMRI 20(3):372–377CrossRefPubMed
3.
Zurück zum Zitat Hayashida Y, Kakeda S, Hiai Y, Ide S, Ogasawara A, Ooki H et al (2014) Diagnosis of intracranial hemorrhagic lesions: comparison between 3D-SWAN (3D T2*-weighted imaging with multi-echo acquisition) and 2D-T2*-weighted imaging. Acta Radiol Stockh Swed 1987 55(2):201–207 Hayashida Y, Kakeda S, Hiai Y, Ide S, Ogasawara A, Ooki H et al (2014) Diagnosis of intracranial hemorrhagic lesions: comparison between 3D-SWAN (3D T2*-weighted imaging with multi-echo acquisition) and 2D-T2*-weighted imaging. Acta Radiol Stockh Swed 1987 55(2):201–207
4.
Zurück zum Zitat Cheng A-L, Batool S, McCreary CR, Lauzon ML, Frayne R, Goyal M et al (2013) Susceptibility-weighted imaging is more reliable than T2*-weighted gradient-recalled echo MRI for detecting microbleeds. Stroke J Cereb Circ 44(10):2782–2786CrossRef Cheng A-L, Batool S, McCreary CR, Lauzon ML, Frayne R, Goyal M et al (2013) Susceptibility-weighted imaging is more reliable than T2*-weighted gradient-recalled echo MRI for detecting microbleeds. Stroke J Cereb Circ 44(10):2782–2786CrossRef
5.
Zurück zum Zitat Nandigam RNK, Viswanathan A, Delgado P, Skehan ME, Smith EE, Rosand J et al (2009) MR imaging detection of cerebral microbleeds: effect of susceptibility-weighted imaging, section thickness, and field strength. AJNR Am J Neuroradiol 30(2):338–343CrossRefPubMed Nandigam RNK, Viswanathan A, Delgado P, Skehan ME, Smith EE, Rosand J et al (2009) MR imaging detection of cerebral microbleeds: effect of susceptibility-weighted imaging, section thickness, and field strength. AJNR Am J Neuroradiol 30(2):338–343CrossRefPubMed
6.
Zurück zum Zitat Cho K-H, Kim JS, Kwon SU, Cho A-H, Kang D-W (2005) Significance of susceptibility vessel sign on T2*-weighted gradient echo imaging for identification of stroke subtypes. Stroke J Cereb Circ 36(11):2379–2383CrossRef Cho K-H, Kim JS, Kwon SU, Cho A-H, Kang D-W (2005) Significance of susceptibility vessel sign on T2*-weighted gradient echo imaging for identification of stroke subtypes. Stroke J Cereb Circ 36(11):2379–2383CrossRef
7.
Zurück zum Zitat Kim HS, Lee DH, Choi CG, Kim SJ, Suh DC (2006) Progression of middle cerebral artery susceptibility sign on T2*-weighted images: its effect on recanalization and clinical outcome after thrombolysis. AJR Am J Roentgenol 187(6):W650–W657CrossRefPubMed Kim HS, Lee DH, Choi CG, Kim SJ, Suh DC (2006) Progression of middle cerebral artery susceptibility sign on T2*-weighted images: its effect on recanalization and clinical outcome after thrombolysis. AJR Am J Roentgenol 187(6):W650–W657CrossRefPubMed
8.
Zurück zum Zitat Kim SK, Yoon W, Kim TS, Kim HS, Heo TW, Park MS (2015) Histologic analysis of retrieved clots in acute ischemic stroke: correlation with stroke etiology and gradient-echo MRI. AJNR Am J Neuroradiol 36(9):1756–1762CrossRefPubMed Kim SK, Yoon W, Kim TS, Kim HS, Heo TW, Park MS (2015) Histologic analysis of retrieved clots in acute ischemic stroke: correlation with stroke etiology and gradient-echo MRI. AJNR Am J Neuroradiol 36(9):1756–1762CrossRefPubMed
9.
Zurück zum Zitat Yamamoto N, Satomi J, Tada Y, Harada M, Izumi Y, Nagahiro S et al (2015) Two-layered susceptibility vessel sign on 3-Tesla T2*-weighted imaging is a predictive biomarker of stroke subtype. Stroke J Cereb Circ 46(1):269–271CrossRef Yamamoto N, Satomi J, Tada Y, Harada M, Izumi Y, Nagahiro S et al (2015) Two-layered susceptibility vessel sign on 3-Tesla T2*-weighted imaging is a predictive biomarker of stroke subtype. Stroke J Cereb Circ 46(1):269–271CrossRef
10.
Zurück zum Zitat Kimura K, Sakamoto Y, Aoki J, Iguchi Y, Shibazaki K, Inoue T (2011) Clinical and MRI predictors of no early recanalization within 1 hour after tissue-type plasminogen activator administration. Stroke J Cereb Circ 42(11):3150–3155CrossRef Kimura K, Sakamoto Y, Aoki J, Iguchi Y, Shibazaki K, Inoue T (2011) Clinical and MRI predictors of no early recanalization within 1 hour after tissue-type plasminogen activator administration. Stroke J Cereb Circ 42(11):3150–3155CrossRef
11.
Zurück zum Zitat Kimura K, Iguchi Y, Shibazaki K, Watanabe M, Iwanaga T, Aoki J (2009) M1 susceptibility vessel sign on T2* as a strong predictor for no early recanalization after IV-t-PA in acute ischemic stroke. Stroke J Cereb Circ 40(9):3130–3132CrossRef Kimura K, Iguchi Y, Shibazaki K, Watanabe M, Iwanaga T, Aoki J (2009) M1 susceptibility vessel sign on T2* as a strong predictor for no early recanalization after IV-t-PA in acute ischemic stroke. Stroke J Cereb Circ 40(9):3130–3132CrossRef
12.
Zurück zum Zitat Aoki J, Kimura K, Shibazaki K, Sakamoto Y, Saji N, Uemura J (2013) Location of the susceptibility vessel sign on T2*-weighted MRI and early recanalization within 1 hour after tissue plasminogen activator administration. Cerebrovasc Dis Extra 3(1):111–120CrossRefPubMedPubMedCentral Aoki J, Kimura K, Shibazaki K, Sakamoto Y, Saji N, Uemura J (2013) Location of the susceptibility vessel sign on T2*-weighted MRI and early recanalization within 1 hour after tissue plasminogen activator administration. Cerebrovasc Dis Extra 3(1):111–120CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Yan S, Hu H, Shi Z, Zhang X, Zhang S, Liebeskind DS et al (2014) Morphology of susceptibility vessel sign predicts middle cerebral artery recanalization after intravenous thrombolysis. Stroke J Cereb Circ 45(9):2795–2797CrossRef Yan S, Hu H, Shi Z, Zhang X, Zhang S, Liebeskind DS et al (2014) Morphology of susceptibility vessel sign predicts middle cerebral artery recanalization after intravenous thrombolysis. Stroke J Cereb Circ 45(9):2795–2797CrossRef
14.
Zurück zum Zitat Yan S, Chen Q, Zhang X, Xu M, Han Q, Shao A et al (2015) Extensive blooming artifact predicts no recanalization after intravenous thrombolysis. Eur J Neurol 26 Yan S, Chen Q, Zhang X, Xu M, Han Q, Shao A et al (2015) Extensive blooming artifact predicts no recanalization after intravenous thrombolysis. Eur J Neurol 26
15.
Zurück zum Zitat Bourcier R, Volpi S, Guyomarch B, Daumas-Duport B, Lintia-Gaultier A, Papagiannaki C et al (2015) Susceptibility vessel sign on MRI predicts favorable clinical outcome in patients with anterior circulation acute stroke treated with mechanical thrombectomy. AJNR Am J Neuroradiol 36(12):2346–2353CrossRefPubMed Bourcier R, Volpi S, Guyomarch B, Daumas-Duport B, Lintia-Gaultier A, Papagiannaki C et al (2015) Susceptibility vessel sign on MRI predicts favorable clinical outcome in patients with anterior circulation acute stroke treated with mechanical thrombectomy. AJNR Am J Neuroradiol 36(12):2346–2353CrossRefPubMed
16.
Zurück zum Zitat Soize S, Batista AL, Rodriguez Regent C, Trystram D, Tisserand M, Turc G et al (2015) Susceptibility vessel sign on T2* magnetic resonance imaging and recanalization results of mechanical thrombectomy with stent retrievers: a multicentre cohort study. Eur J Neurol 22(6):967–972CrossRefPubMed Soize S, Batista AL, Rodriguez Regent C, Trystram D, Tisserand M, Turc G et al (2015) Susceptibility vessel sign on T2* magnetic resonance imaging and recanalization results of mechanical thrombectomy with stent retrievers: a multicentre cohort study. Eur J Neurol 22(6):967–972CrossRefPubMed
17.
Zurück zum Zitat Allibert R, Billon Grand C, Vuillier F, Cattin F, Muzard E, Biondi A et al (2014) Advantages of susceptibility-weighted magnetic resonance sequences in the visualization of intravascular thrombi in acute ischemic stroke. Int J Stroke Off J Int Stroke Soc 9(8):980–984CrossRef Allibert R, Billon Grand C, Vuillier F, Cattin F, Muzard E, Biondi A et al (2014) Advantages of susceptibility-weighted magnetic resonance sequences in the visualization of intravascular thrombi in acute ischemic stroke. Int J Stroke Off J Int Stroke Soc 9(8):980–984CrossRef
18.
Zurück zum Zitat Hodel J, Leclerc X, Khaled W, Tamazyan R, Rodallec M, Gerber S et al (2014) Comparison of 3D multi-echo gradient-echo and 2D T2* MR sequences for the detection of arterial thrombus in patients with acute stroke. Eur Radiol 24(3):762–769CrossRefPubMed Hodel J, Leclerc X, Khaled W, Tamazyan R, Rodallec M, Gerber S et al (2014) Comparison of 3D multi-echo gradient-echo and 2D T2* MR sequences for the detection of arterial thrombus in patients with acute stroke. Eur Radiol 24(3):762–769CrossRefPubMed
19.
Zurück zum Zitat Park M-G, Yoon CH, Baik SK, Park K-P (2015) Susceptibility vessel sign for intra-arterial thrombus in acute posterior cerebral artery infarction. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc 24(6):1229–1234CrossRef Park M-G, Yoon CH, Baik SK, Park K-P (2015) Susceptibility vessel sign for intra-arterial thrombus in acute posterior cerebral artery infarction. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc 24(6):1229–1234CrossRef
20.
Zurück zum Zitat Park M-G, Oh S-J, Baik SK, Jung DS, Park K-P (2016) Susceptibility-weighted imaging for detection of thrombus in acute cardioembolic stroke. J Stroke 18(1):73–79CrossRefPubMedPubMedCentral Park M-G, Oh S-J, Baik SK, Jung DS, Park K-P (2016) Susceptibility-weighted imaging for detection of thrombus in acute cardioembolic stroke. J Stroke 18(1):73–79CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Radbruch A, Mucke J, Schweser F, Deistung A, Ringleb PA, Ziener CH et al (2013) Comparison of susceptibility weighted imaging and TOF-angiography for the detection of thrombi in acute stroke. PLoS One 8(5), e63459CrossRefPubMedPubMedCentral Radbruch A, Mucke J, Schweser F, Deistung A, Ringleb PA, Ziener CH et al (2013) Comparison of susceptibility weighted imaging and TOF-angiography for the detection of thrombi in acute stroke. PLoS One 8(5), e63459CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Gratz PP, Schroth G, Gralla J, Mattle HP, Fischer U, Jung S et al (2015) Whole-brain susceptibility-weighted thrombus imaging in stroke: fragmented thrombi predict worse outcome. AJNR Am J Neuroradiol 36(7):1277–1282CrossRefPubMed Gratz PP, Schroth G, Gralla J, Mattle HP, Fischer U, Jung S et al (2015) Whole-brain susceptibility-weighted thrombus imaging in stroke: fragmented thrombi predict worse outcome. AJNR Am J Neuroradiol 36(7):1277–1282CrossRefPubMed
23.
Zurück zum Zitat Patzig M, Feddersen B, Haegler K, Olzowy B, Mees K, Fischer R et al (2015) Susceptibility-weighted angiography visualizes hypoxia in cerebral veins. Invest Radiol 50(6):397–400CrossRefPubMed Patzig M, Feddersen B, Haegler K, Olzowy B, Mees K, Fischer R et al (2015) Susceptibility-weighted angiography visualizes hypoxia in cerebral veins. Invest Radiol 50(6):397–400CrossRefPubMed
24.
Zurück zum Zitat Chalian M, Tekes A, Meoded A, Poretti A, Huisman TAGM (2011) Susceptibility-weighted imaging (SWI): a potential non-invasive imaging tool for characterizing ischemic brain injury? J Neuroradiol 38(3):187–190CrossRefPubMed Chalian M, Tekes A, Meoded A, Poretti A, Huisman TAGM (2011) Susceptibility-weighted imaging (SWI): a potential non-invasive imaging tool for characterizing ischemic brain injury? J Neuroradiol 38(3):187–190CrossRefPubMed
25.
Zurück zum Zitat Park M-G, Yang T-I, Oh S-J, Baik SK, Kang YH, Park K-P (2014) Multiple hypointense vessels on susceptibility-weighted imaging in acute ischemic stroke: surrogate marker of oxygen extraction fraction in penumbra? Cerebrovasc Dis Basel Switz 38(4):254–261CrossRef Park M-G, Yang T-I, Oh S-J, Baik SK, Kang YH, Park K-P (2014) Multiple hypointense vessels on susceptibility-weighted imaging in acute ischemic stroke: surrogate marker of oxygen extraction fraction in penumbra? Cerebrovasc Dis Basel Switz 38(4):254–261CrossRef
26.
Zurück zum Zitat Chen C-Y, Chen C-I, Tsai FY, Tsai P-H, Chan WP (2015) Prominent vessel sign on susceptibility-weighted imaging in acute stroke: prediction of infarct growth and clinical outcome. PLoS One 10(6):e0131118CrossRefPubMedPubMedCentral Chen C-Y, Chen C-I, Tsai FY, Tsai P-H, Chan WP (2015) Prominent vessel sign on susceptibility-weighted imaging in acute stroke: prediction of infarct growth and clinical outcome. PLoS One 10(6):e0131118CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Luo S, Yang L, Wang L (2015) Comparison of susceptibility-weighted and perfusion-weighted magnetic resonance imaging in the detection of penumbra in acute ischemic stroke. J Neuroradiol 42(5):255–260CrossRefPubMed Luo S, Yang L, Wang L (2015) Comparison of susceptibility-weighted and perfusion-weighted magnetic resonance imaging in the detection of penumbra in acute ischemic stroke. J Neuroradiol 42(5):255–260CrossRefPubMed
28.
Zurück zum Zitat Terasawa Y, Yamamoto N, Morigaki R, Fujita K, Izumi Y, Satomi J et al (2014) Brush sign on 3-T T2*-weighted MRI as a potential predictor of hemorrhagic transformation after tissue plasminogen activator therapy. Stroke J Cereb Circ 45(1):274–276CrossRef Terasawa Y, Yamamoto N, Morigaki R, Fujita K, Izumi Y, Satomi J et al (2014) Brush sign on 3-T T2*-weighted MRI as a potential predictor of hemorrhagic transformation after tissue plasminogen activator therapy. Stroke J Cereb Circ 45(1):274–276CrossRef
29.
Zurück zum Zitat Alsop DC, Detre JA, Golay X, Günther M, Hendrikse J, Hernandez-Garcia L et al (2015) Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med 73(1):102–116CrossRefPubMed Alsop DC, Detre JA, Golay X, Günther M, Hendrikse J, Hernandez-Garcia L et al (2015) Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: a consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia. Magn Reson Med 73(1):102–116CrossRefPubMed
30.
Zurück zum Zitat Bivard A, Krishnamurthy V, Stanwell P, Levi C, Spratt NJ, Davis S et al (2014) Arterial spin labeling versus bolus-tracking perfusion in hyperacute stroke. Stroke J Cereb Circ 45(1):127–133CrossRef Bivard A, Krishnamurthy V, Stanwell P, Levi C, Spratt NJ, Davis S et al (2014) Arterial spin labeling versus bolus-tracking perfusion in hyperacute stroke. Stroke J Cereb Circ 45(1):127–133CrossRef
31.
Zurück zum Zitat Bokkers RPH, Hernandez DA, Merino JG, Mirasol RV, van Osch MJ, Hendrikse J et al (2012) Whole-brain arterial spin labeling perfusion MRI in patients with acute stroke. Stroke J Cereb Circ 43(5):1290–1294CrossRef Bokkers RPH, Hernandez DA, Merino JG, Mirasol RV, van Osch MJ, Hendrikse J et al (2012) Whole-brain arterial spin labeling perfusion MRI in patients with acute stroke. Stroke J Cereb Circ 43(5):1290–1294CrossRef
32.
Zurück zum Zitat Mirasol RV, Bokkers RPH, Hernandez DA, Merino JG, Luby M, Warach S et al (2014) Assessing reperfusion with whole-brain arterial spin labeling: a noninvasive alternative to gadolinium. Stroke J Cereb Circ 45(2):456–461CrossRef Mirasol RV, Bokkers RPH, Hernandez DA, Merino JG, Luby M, Warach S et al (2014) Assessing reperfusion with whole-brain arterial spin labeling: a noninvasive alternative to gadolinium. Stroke J Cereb Circ 45(2):456–461CrossRef
33.
Zurück zum Zitat Wang DJJ, Alger JR, Qiao JX, Hao Q, Hou S, Fiaz R et al (2012) The value of arterial spin-labeled perfusion imaging in acute ischemic stroke: comparison with dynamic susceptibility contrast-enhanced MRI. Stroke J Cereb Circ 43(4):1018–1024CrossRef Wang DJJ, Alger JR, Qiao JX, Hao Q, Hou S, Fiaz R et al (2012) The value of arterial spin-labeled perfusion imaging in acute ischemic stroke: comparison with dynamic susceptibility contrast-enhanced MRI. Stroke J Cereb Circ 43(4):1018–1024CrossRef
34.
Zurück zum Zitat Niibo T, Ohta H, Yonenaga K, Ikushima I, Miyata S, Takeshima H (2013) Arterial spin-labeled perfusion imaging to predict mismatch in acute ischemic stroke. Stroke J Cereb Circ 44(9):2601–2603CrossRef Niibo T, Ohta H, Yonenaga K, Ikushima I, Miyata S, Takeshima H (2013) Arterial spin-labeled perfusion imaging to predict mismatch in acute ischemic stroke. Stroke J Cereb Circ 44(9):2601–2603CrossRef
35.
Zurück zum Zitat Wang J, Alsop DC, Li L, Listerud J, Gonzalez-At JB, Schnall MD et al (2002) Comparison of quantitative perfusion imaging using arterial spin labeling at 1.5 and 4.0 Tesla. Magn Reson Med 48(2):242–254CrossRefPubMed Wang J, Alsop DC, Li L, Listerud J, Gonzalez-At JB, Schnall MD et al (2002) Comparison of quantitative perfusion imaging using arterial spin labeling at 1.5 and 4.0 Tesla. Magn Reson Med 48(2):242–254CrossRefPubMed
36.
Zurück zum Zitat Majer M, Mejdoubi M, Schertz M, Colombani S, Arrigo A (2015) Raw arterial spin labeling data can help identify arterial occlusion in acute ischemic stroke. Stroke J Cereb Circ 46(6):e141–e144CrossRef Majer M, Mejdoubi M, Schertz M, Colombani S, Arrigo A (2015) Raw arterial spin labeling data can help identify arterial occlusion in acute ischemic stroke. Stroke J Cereb Circ 46(6):e141–e144CrossRef
37.
Zurück zum Zitat Tada Y, Satomi J, Abe T, Kuwayama K, Sogabe S, Fujita K et al (2014) Intra-arterial signal on arterial spin labeling perfusion MRI to identify the presence of acute middle cerebral artery occlusion. Cerebrovasc Dis Basel Switz 38(3):191–196CrossRef Tada Y, Satomi J, Abe T, Kuwayama K, Sogabe S, Fujita K et al (2014) Intra-arterial signal on arterial spin labeling perfusion MRI to identify the presence of acute middle cerebral artery occlusion. Cerebrovasc Dis Basel Switz 38(3):191–196CrossRef
38.
Zurück zum Zitat Yoo R-E, Yun TJ, Rhim JH, Yoon B-W, Kang KM, Choi SH et al (2015) Bright vessel appearance on arterial spin labeling MRI for localizing arterial occlusion in acute ischemic stroke. Stroke J Cereb Circ 46(2):564–567CrossRef Yoo R-E, Yun TJ, Rhim JH, Yoon B-W, Kang KM, Choi SH et al (2015) Bright vessel appearance on arterial spin labeling MRI for localizing arterial occlusion in acute ischemic stroke. Stroke J Cereb Circ 46(2):564–567CrossRef
39.
Zurück zum Zitat Bivard A, Stanwell P, Levi C, Parsons M (2013) Arterial spin labeling identifies tissue salvage and good clinical recovery after acute ischemic stroke. J Neuroimaging Off J Am Soc Neuroimaging 23(3):391–396CrossRef Bivard A, Stanwell P, Levi C, Parsons M (2013) Arterial spin labeling identifies tissue salvage and good clinical recovery after acute ischemic stroke. J Neuroimaging Off J Am Soc Neuroimaging 23(3):391–396CrossRef
40.
Zurück zum Zitat Viallon M, Altrichter S, Pereira VM, Nguyen D, Sekoranja L, Federspiel A et al (2010) Combined use of pulsed arterial spin-labeling and susceptibility-weighted imaging in stroke at 3T. Eur Neurol 64(5):286–296CrossRefPubMed Viallon M, Altrichter S, Pereira VM, Nguyen D, Sekoranja L, Federspiel A et al (2010) Combined use of pulsed arterial spin-labeling and susceptibility-weighted imaging in stroke at 3T. Eur Neurol 64(5):286–296CrossRefPubMed
41.
Zurück zum Zitat Yu S, Liebeskind DS, Dua S, Wilhalme H, Elashoff D, Qiao XJ et al (2015) Postischemic hyperperfusion on arterial spin labeled perfusion MRI is linked to hemorrhagic transformation in stroke. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab 35(4):630–637CrossRef Yu S, Liebeskind DS, Dua S, Wilhalme H, Elashoff D, Qiao XJ et al (2015) Postischemic hyperperfusion on arterial spin labeled perfusion MRI is linked to hemorrhagic transformation in stroke. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab 35(4):630–637CrossRef
42.
Zurück zum Zitat Artto V, Putaala J, Strbian D, Meretoja A, Piironen K, Liebkind R et al (2012) Stroke mimics and intravenous thrombolysis. Ann Emerg Med 59(1):27–32CrossRefPubMed Artto V, Putaala J, Strbian D, Meretoja A, Piironen K, Liebkind R et al (2012) Stroke mimics and intravenous thrombolysis. Ann Emerg Med 59(1):27–32CrossRefPubMed
43.
Zurück zum Zitat Förster A, Griebe M, Wolf ME, Szabo K, Hennerici MG, Kern R (2012) How to identify stroke mimics in patients eligible for intravenous thrombolysis? J Neurol 259(7):1347–1353CrossRefPubMed Förster A, Griebe M, Wolf ME, Szabo K, Hennerici MG, Kern R (2012) How to identify stroke mimics in patients eligible for intravenous thrombolysis? J Neurol 259(7):1347–1353CrossRefPubMed
44.
Zurück zum Zitat Guillan M, Alonso-Canovas A, Gonzalez-Valcarcel J, Garcia Barragan N, Garcia Caldentey J, Hernandez-Medrano I et al (2012) Stroke mimics treated with thrombolysis: further evidence on safety and distinctive clinical features. Cerebrovasc Dis Basel Switz 34(2):115–120CrossRef Guillan M, Alonso-Canovas A, Gonzalez-Valcarcel J, Garcia Barragan N, Garcia Caldentey J, Hernandez-Medrano I et al (2012) Stroke mimics treated with thrombolysis: further evidence on safety and distinctive clinical features. Cerebrovasc Dis Basel Switz 34(2):115–120CrossRef
45.
Zurück zum Zitat Lewandowski C, Mays-Wilson K, Miller J, Penstone P, Miller DJ, Bakoulas K et al (2015) Safety and outcomes in stroke mimics after intravenous tissue plasminogen activator administration: a single-center experience. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc 24(1):48–52CrossRef Lewandowski C, Mays-Wilson K, Miller J, Penstone P, Miller DJ, Bakoulas K et al (2015) Safety and outcomes in stroke mimics after intravenous tissue plasminogen activator administration: a single-center experience. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc 24(1):48–52CrossRef
46.
Zurück zum Zitat Tsivgoulis G, Zand R, Katsanos AH, Goyal N, Uchino K, Chang J et al (2015) Safety of intravenous thrombolysis in stroke mimics: prospective 5-year study and comprehensive meta-analysis. Stroke J Cereb Circ 46(5):1281–1287CrossRef Tsivgoulis G, Zand R, Katsanos AH, Goyal N, Uchino K, Chang J et al (2015) Safety of intravenous thrombolysis in stroke mimics: prospective 5-year study and comprehensive meta-analysis. Stroke J Cereb Circ 46(5):1281–1287CrossRef
47.
Zurück zum Zitat Winkler DT, Fluri F, Fuhr P, Wetzel SG, Lyrer PA, Ruegg S et al (2009) Thrombolysis in stroke mimics: frequency, clinical characteristics, and outcome. Stroke J Cereb Circ 40(4):1522–1525CrossRef Winkler DT, Fluri F, Fuhr P, Wetzel SG, Lyrer PA, Ruegg S et al (2009) Thrombolysis in stroke mimics: frequency, clinical characteristics, and outcome. Stroke J Cereb Circ 40(4):1522–1525CrossRef
48.
Zurück zum Zitat Zinkstok SM, Engelter ST, Gensicke H, Lyrer PA, Ringleb PA, Artto V et al (2013) Safety of thrombolysis in stroke mimics: results from a multicenter cohort study. Stroke J Cereb Circ 44(4):1080–1084CrossRef Zinkstok SM, Engelter ST, Gensicke H, Lyrer PA, Ringleb PA, Artto V et al (2013) Safety of thrombolysis in stroke mimics: results from a multicenter cohort study. Stroke J Cereb Circ 44(4):1080–1084CrossRef
49.
Zurück zum Zitat Goyal N, Male S, Al Wafai A, Bellamkonda S, Zand R (2015) Cost burden of stroke mimics and transient ischemic attack after intravenous tissue plasminogen activator treatment. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc 24(4):828–833CrossRef Goyal N, Male S, Al Wafai A, Bellamkonda S, Zand R (2015) Cost burden of stroke mimics and transient ischemic attack after intravenous tissue plasminogen activator treatment. J Stroke Cerebrovasc Dis Off J Natl Stroke Assoc 24(4):828–833CrossRef
50.
Zurück zum Zitat Altrichter S, Pendse N, Wissmeyer M, Jägersberg M, Federspiel A, Viallon M et al (2009) Arterial spin-labeling demonstrates ictal cortical hyperperfusion in epilepsy secondary to hemimegalencephaly. J Neuroradiol J Neuroradiol 36(5):303–305CrossRefPubMed Altrichter S, Pendse N, Wissmeyer M, Jägersberg M, Federspiel A, Viallon M et al (2009) Arterial spin-labeling demonstrates ictal cortical hyperperfusion in epilepsy secondary to hemimegalencephaly. J Neuroradiol J Neuroradiol 36(5):303–305CrossRefPubMed
51.
Zurück zum Zitat Deibler AR, Pollock JM, Kraft RA, Tan H, Burdette JH, Maldjian JA (2008) Arterial spin-labeling in routine clinical practice, part 3: hyperperfusion patterns. AJNR Am J Neuroradiol 29(8):1428–1435CrossRefPubMedPubMedCentral Deibler AR, Pollock JM, Kraft RA, Tan H, Burdette JH, Maldjian JA (2008) Arterial spin-labeling in routine clinical practice, part 3: hyperperfusion patterns. AJNR Am J Neuroradiol 29(8):1428–1435CrossRefPubMedPubMedCentral
52.
Zurück zum Zitat Oishi M, Ishida G, Morii K, Hasegawa K, Sato M, Fujii Y (2012) Ictal focal hyperperfusion demonstrated by arterial spin-labeling perfusion MRI in partial epilepsy status. Neuroradiology 54(6):653–656CrossRefPubMed Oishi M, Ishida G, Morii K, Hasegawa K, Sato M, Fujii Y (2012) Ictal focal hyperperfusion demonstrated by arterial spin-labeling perfusion MRI in partial epilepsy status. Neuroradiology 54(6):653–656CrossRefPubMed
53.
Zurück zum Zitat Danière F, Edjlali-Goujon M, Mellerio C, Turc G, Naggara O, Tselikas L et al (2014) MR screening of candidates for thrombolysis: how to identify stroke mimics? J Neuroradiol 41(5):283–295CrossRefPubMed Danière F, Edjlali-Goujon M, Mellerio C, Turc G, Naggara O, Tselikas L et al (2014) MR screening of candidates for thrombolysis: how to identify stroke mimics? J Neuroradiol 41(5):283–295CrossRefPubMed
54.
Zurück zum Zitat Pendse N, Wissmeyer M, Altrichter S, Vargas M, Delavelle J, Viallon M et al (2010) Interictal arterial spin-labeling MRI perfusion in intractable epilepsy. J Neuroradiol J Neuroradiol 37(1):60–63CrossRefPubMed Pendse N, Wissmeyer M, Altrichter S, Vargas M, Delavelle J, Viallon M et al (2010) Interictal arterial spin-labeling MRI perfusion in intractable epilepsy. J Neuroradiol J Neuroradiol 37(1):60–63CrossRefPubMed
55.
Zurück zum Zitat Floery D, Vosko MR, Fellner FA, Fellner C, Ginthoer C, Gruber F et al (2012) Acute-onset migrainous aura mimicking acute stroke: MR perfusion imaging features. AJNR Am J Neuroradiol 33(8):1546–1552CrossRefPubMed Floery D, Vosko MR, Fellner FA, Fellner C, Ginthoer C, Gruber F et al (2012) Acute-onset migrainous aura mimicking acute stroke: MR perfusion imaging features. AJNR Am J Neuroradiol 33(8):1546–1552CrossRefPubMed
56.
Zurück zum Zitat Förster A, Wenz H, Kerl HU, Brockmann MA, Groden C (2014) Perfusion patterns in migraine with aura. Cephalalgia Int J Headache 34(11):870–876CrossRef Förster A, Wenz H, Kerl HU, Brockmann MA, Groden C (2014) Perfusion patterns in migraine with aura. Cephalalgia Int J Headache 34(11):870–876CrossRef
57.
Zurück zum Zitat Karaarslan E, Uluus S, Kürtüncü M (2001) Susceptibility-weighted Imaging in migraine with aura. AJNR Am J Neuroradiol 32(1):E5–E7 Karaarslan E, Uluus S, Kürtüncü M (2001) Susceptibility-weighted Imaging in migraine with aura. AJNR Am J Neuroradiol 32(1):E5–E7
58.
Zurück zum Zitat Pollock JM, Deibler AR, Burdette JH, Kraft RA, Tan H, Evans AB et al (2008) Migraine associated cerebral hyperperfusion with arterial spin-labeled MR imaging. AJNR Am J Neuroradiol 29(8):1494–1497CrossRefPubMed Pollock JM, Deibler AR, Burdette JH, Kraft RA, Tan H, Evans AB et al (2008) Migraine associated cerebral hyperperfusion with arterial spin-labeled MR imaging. AJNR Am J Neuroradiol 29(8):1494–1497CrossRefPubMed
Metadaten
Titel
ASL and susceptibility-weighted imaging contribution to the management of acute ischaemic stroke
verfasst von
Sébastien Verclytte
Olivier Fisch
Lucie Colas
Olivier Vanaerde
Manuel Toledano
Jean-François Budzik
Publikationsdatum
07.11.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Insights into Imaging / Ausgabe 1/2017
Elektronische ISSN: 1869-4101
DOI
https://doi.org/10.1007/s13244-016-0529-y

Weitere Artikel der Ausgabe 1/2017

Insights into Imaging 1/2017 Zur Ausgabe

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.